We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Last year, Pfizer stopped manufacturing and recalled products from a Hospira sterile injectables plant in India that the FDA has repeatedly criticized. It recently announced it would close the plant.